BridgeMD
Clinical trial on the assessment of mucosal visualization quality and diagnostic performance in small bowel capsule endoscopy using different preparation protocols
EU CTIS ID: 2025-520671-38-00
What this study is testing
To evaluate and compare the degree of cleaning and visualization of the small intestine mucosa in patients undergoing capsule endoscopy
- Phase III and phase IV (Integrated)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients aged 18 years or older who are indicated to undergo a small bowel study using capsule endoscopy and whose indication is included in standard clinical practice
- They will provide signed informed consent for performing capsule endoscopy.
- Provide signed and dated informed consent for entry into the clinical trial
You likely can't join if
- Suspected or diagnosed gastrointestinal obstruction/perforation.
- Known small bowel strictures
- Patients with severe gastroparesis
- In case of previous Patency® capsule production: Deformed retention or expulsion of the capsule.
- pregnant
- Patients with severe liver, cardiovascular or kidney disease that contraindicates preparation with polyethylene glycol (Movipep®).
See the full eligibility criteria
- Patients aged 18 years or older who are indicated to undergo a small bowel study using capsule endoscopy and whose indication is included in standard clinical practice
- They will provide signed informed consent for performing capsule endoscopy.
- Provide signed and dated informed consent for entry into the clinical trial
- Suspected or diagnosed gastrointestinal obstruction/perforation.
- Known small bowel strictures
- Patients with severe gastroparesis
- In case of previous Patency® capsule production: Deformed retention or expulsion of the capsule.
- pregnant
- Patients with severe liver, cardiovascular or kidney disease that contraindicates preparation with polyethylene glycol (Movipep®).
- Patients who present or have presented any adverse reaction or allergy to polyethylene glycol (Moviprep ®) or simethicone.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.